GE HealthCare Technologies Inc. (NASDAQ:GEHC) Insider Purchases $100,623.80 in Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) insider Frank R. Jimenez bought 1,315 shares of the firm's stock in a transaction that occurred on Wednesday, May 1st. The shares were acquired at an average price of $76.52 per share, with a total value of $100,623.80. Following the acquisition, the insider now owns 75,796 shares of the company's stock, valued at $5,799,909.92. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

GE HealthCare Technologies Trading Down 0.5 %

NASDAQ:GEHC traded down $0.43 on Thursday, reaching $77.83. The company's stock had a trading volume of 2,995,442 shares, compared to its average volume of 3,461,109. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. The firm has a market cap of $35.52 billion, a price-to-earnings ratio of 22.76, a price-to-earnings-growth ratio of 2.65 and a beta of 1.26. The stock has a 50 day moving average price of $88.64 and a 200 day moving average price of $78.81.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, meeting analysts' consensus estimates of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business had revenue of $4.65 billion during the quarter, compared to analysts' expectations of $4.80 billion. During the same period in the previous year, the firm posted $0.85 earnings per share. The company's revenue was down 1.2% on a year-over-year basis. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies's payout ratio is presently 3.51%.

Analysts Set New Price Targets

Several equities research analysts recently commented on GEHC shares. Citigroup increased their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a "buy" rating in a research report on Wednesday, April 3rd. Argus lifted their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a "buy" rating in a research note on Monday, April 1st. Bank of America reduced their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a "neutral" rating on the stock in a research note on Wednesday. UBS Group raised GE HealthCare Technologies from a "sell" rating to a "neutral" rating and lifted their price objective for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. Finally, HSBC initiated coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a "buy" rating and a $100.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and an average target price of $95.00.

Institutional Investors Weigh In On GE HealthCare Technologies

Institutional investors have recently modified their holdings of the company. Wynn Capital LLC grew its stake in GE HealthCare Technologies by 4.1% during the 1st quarter. Wynn Capital LLC now owns 3,125 shares of the company's stock worth $284,000 after purchasing an additional 122 shares in the last quarter. Byrne Asset Management LLC grew its stake in GE HealthCare Technologies by 0.8% during the 1st quarter. Byrne Asset Management LLC now owns 16,424 shares of the company's stock worth $1,493,000 after purchasing an additional 126 shares in the last quarter. WASHINGTON TRUST Co grew its stake in GE HealthCare Technologies by 7.7% during the 1st quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company's stock worth $168,000 after purchasing an additional 133 shares in the last quarter. Fiduciary Trust Co grew its stake in GE HealthCare Technologies by 1.8% during the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company's stock worth $595,000 after purchasing an additional 133 shares in the last quarter. Finally, Quent Capital LLC lifted its holdings in GE HealthCare Technologies by 21.3% during the 1st quarter. Quent Capital LLC now owns 780 shares of the company's stock worth $71,000 after buying an additional 137 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.